Nanordica Medical OÜ
Nanordica Medical OÜ is a OÜ based in Tallinn, registry code 14710113, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €82 294 with 13 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 82 294 €above 81% of companiesindustry median 14 442 € · companies in the industry: 318
- Labour taxes per employee 6 123 €above 86% of companiesindustry median 2 218 € · companies in the industry: 234
- Revenue · 2025 9 712 €above 70% of companiesindustry median 0 € · companies in the industry: 1 073
- Net profit margin · 2025 9.7 %above 46% of companiesindustry median 13.5 % · companies in the industry: 597
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 82 294 | 72 062 | 79 596 | 13 |
| Q2 2026 | 111 890 | 69 036 | 76 336 | 13 |
| Q1 2026 | 362 502 | 79 316 | 86 864 | 12 |
| Q4 2025 | 124 923 | 83 861 | 91 945 | 12 |
| Q3 2025 | 60 221 | 81 002 | 89 104 | 14 |
| Q2 2025 | 111 137 | 73 447 | 80 884 | 13 |
| Q1 2025 | 58 132 | 68 778 | 75 411 | 12 |
| Q4 2024 | 48 261 | 66 468 | 72 057 | 11 |
| Q3 2024 | 16 656 | 68 036 | 73 705 | 12 |
| Q2 2024 | 58 916 | 61 311 | 66 471 | 12 |
| Q1 2024 | 15 471 | 57 186 | 61 993 | 10 |
| Q4 2023 | 28 441 | 57 095 | 61 900 | 10 |
| Q3 2023 | 18 480 | 52 002 | 56 379 | 10 |
| Q2 2023 | 14 863 | 42 536 | 46 113 | 7 |
| Q1 2023 | 685 | 29 410 | 31 256 | 6 |
| Q4 2022 | 5 065 | 6 349 | 6 648 | 1 |
| Q3 2022 | 22 600 | 4 585 | 4 971 | 1 |
| Q2 2022 | 400 | — | — | 1 |
| Q1 2022 | — | — | — | — |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 9 712 | 946 | 786 520 | 2 621 041 | 2 425 903 | 11 |
| 2024 | 18 074 | -62 335 | 654 974 | 2 999 523 | 2 103 260 | 9 |
| 2023 | 2 880 | 113 042 | 504 547 | 1 004 663 | 185 020 | 6 |
| 2022 | 0 | 39 379 | 28 055 | 87 422 | 70 978 | 1 |
| 2021 | 0 | -1 534 | 0 | 5 940 | 2 930 | 0 |
| 2020 | 0 | -117 | 0 | 7 416 | 4 404 | 0 |
| 2019 | — | -1 389 | 0 | 2 336 | 1 611 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 28 May 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 6 May 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 31 May 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 18 Apr 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 8 Mar 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 30 Mar 2021 | Company’s own | e-Äriregister |
| 2019 | 23 Apr 2019 – 31 Dec 2019 | 19 May 2020 | Company’s own | e-Äriregister |
Board
- Grigory VasilievBoard member · since 23 Apr 2019
- Olesja BondarenkoBoard member · since 23 Apr 2019
- Meelis KadajaBoard member · since 13 Sep 2022
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Olesja BondarenkoNatural person · 3 094 €
- Meelis KadajaNatural person · 2 893 €
- Grigory VasilievNatural person · 2 691 €
- Usaldusfond Specialist VC Primary and Secondary Fund IILegal person · 16392077 · 2 297 €
- Nanordica Medical OÜLegal person · 14710113 · 1 805 €
- 2C Ventures Fund I usaldusfondLegal person · 16864903 · 1 507 €
- Usaldusfond Superangel TwoLegal person · 16519922 · 1 198 €
- Nanus Nordicus OÜLegal person · 17122173 · 1 036 €
- AS AMALFILegal person · 10411419 · 751 €
- HF Ventures I OÜLegal person · 16061050 · 474 €
- Sentosa Capital OÜLegal person · 10687713 · 351 €
- OÜ ANEMOSLegal person · 11053577 · 256 €
- Tehnopol Ventures OÜLegal person · 16135392 · 230 €
- Andres ValknaNatural person · 217 €
- VLAN Ventures GmbHLegal person · 199 €
- Anna-Liisa KuboNatural person · 159 €
- OÜ TikrikastLegal person · 14476887 · 117 €
- Tatjana BondarenkoNatural person · 85 €
- Ilja MakarenkovNatural person · 77 €
- Venturebeam Markets ASLegal person · 12917885 · 12 €
Owner in
- 9.28%
Beneficial owners
- Grigory VasilievMember of a senior management body (management or supervisory board) · since 27 Mar 2024
- Meelis KadajaMember of a senior management body (management or supervisory board) · since 27 Mar 2024
- Olesja BondarenkoMember of a senior management body (management or supervisory board) · since 27 Mar 2024
Founders and other persons
- Anna-Liisa KuboFounder · 1 000 € · 23 Apr 2019
- Grigory VasilievFounder · 1 000 € · 23 Apr 2019
- Olesja BondarenkoFounder · 1 000 € · 23 Apr 2019
Related companies
Activities (EMTAK)
- 72101Research and experimental development on natural sciences and engineering Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50118206 / 16 12 Jun 2026 |
Amendment entry | In force 12 Jun 2026 |
||
| Ä 50118206 / 15 21 Apr 2026 |
Amendment entry | In force 21 Apr 2026 |
||
| Ä 50118206 / 14 3 Jun 2025 |
Amendment entry | In force 3 Jun 2025 |
||
| Ä 50118206 / M3 15 May 2025 |
Ruling to eliminate deficiencies | 3 Jun 2025 | Deficiencies eliminated 3 Jun 2025 |
|
| Ä 50118206 / 13 7 Jun 2024 |
Amendment entry | In force 7 Jun 2024 |
||
| Ä 50118206 / 12 7 Feb 2024 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 7 Feb 2024 |
||
| Ä 50118206 / 11 1 Mar 2023 |
Amendment entry | In force 1 Mar 2023 |
||
| Ä 50118206 / 10 12 Dec 2022 |
Amendment entry | In force 12 Dec 2022 |
||
| Ä 50118206 / 9 9 Dec 2022 |
Amendment entry | In force 9 Dec 2022 |
||
| Ä 50118206 / 8 29 Nov 2022 |
Amendment entry | In force 29 Nov 2022 |
||
| Ä 50118206 / 7 15 Nov 2022 |
Entry refused | In force 2 Dec 2022 |
||
| Ä 50118206 / 6 13 Sep 2022 |
Amendment entry | In force 13 Sep 2022 |
||
| Ä 50118206 / 5 22 Feb 2022 |
Amendment entry | In force 22 Feb 2022 |
||
| Ä 50118206 / M2 16 Feb 2022 |
Ruling to eliminate deficiencies | 3 Mar 2022 | Deficiencies eliminated 22 Feb 2022 |
|
| Ä 50118206 / M1 26 Jul 2021 |
Ruling to eliminate deficiencies | 2 Aug 2021 | Deficiencies eliminated 26 Jul 2021 |
|
| Ä 50118206 / 4 26 Jul 2021 |
Amendment entry | In force 26 Jul 2021 |
||
| Ä 50118206 / 3 15 Jun 2020 |
Amendment under Commercial Code § 525 (2) | In force 15 Jun 2020 |
||
| Ä 50118206 / 2 28 Aug 2019 |
Amendment under Commercial Code § 525 (2) | In force 28 Aug 2019 |
||
| Ä 50118206 23 Apr 2019 |
First entry | In force 23 Apr 2019 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data